Personalized prostate cancer care: from screening to treatment

por Conran, Carly A, Brendler, Charles B, Xu, Jianfeng
Publicado 2016

Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer

por Conran, Carly A, Na, Rong, Chen, Haitao, Jiang, Deke, Lin, Xiaoling, Zheng, S Lilly, Brendler, Charles B, Xu, Jianfeng
Publicado 2016

A Longitudinal Study of Predictors of Sexual Dysfunction in Men on Active Surveillance for Prostate Cancer

por Pearce, Shane M, Wang, Chi-Hsiung E, Victorson, David E, Helfand, Brian T, Novakovic, Kristian R, Brendler, Charles B, Albaugh, Jeffrey A
Publicado 2015

Assessing the clinical utility of genetic risk scores for targeted cancer screening

por Conran, Carly A., Shi, Zhuqing, Resurreccion, William Kyle, Na, Rong, Helfand, Brian T., Genova, Elena, Zheng, Siqun Lilly, Brendler, Charles B., Xu, Jianfeng
Publicado 2021

Nanocytological Field Carcinogenesis Detection to Mitigate Overdiagnosis of Prostate Cancer: A Proof of Concept Study

por Roy, Hemant K., Brendler, Charles B., Subramanian, Hariharan, Zhang, Di, Maneval, Charles, Chandler, John, Bowen, Leah, Kaul, Karen L., Helfand, Brian T., Wang, Chi-Hsiung, Quinn, Margo, Petkewicz, Jacqueline, Paterakos, Michael, Backman, Vadim
Publicado 2015

Race-specific genetic risk score is more accurate than nonrace-specific genetic risk score for predicting prostate cancer and high-grade diseases

por Na, Rong, Ye, Dingwei, Qi, Jun, Liu, Fang, Lin, Xiaoling, Helfand, Brian T, Brendler, Charles B, Conran, Carly, Gong, Jian, Wu, Yishuo, Gao, Xu, Chen, Yaqing, Zheng, S Lilly, Mo, Zengnan, Ding, Qiang, Sun, Yinghao, Xu, Jianfeng
Publicado 2016